News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Siegel Jolie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4/A
| Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,102 shares
@ $7.01, valued at
$7.7k
|
|
| 05/27/2022 |
4
| Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Exercised 3,750 options to buy
@ $0 |
|
| 02/16/2022 |
4
| Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $22.71, valued at
$2M
Granted 26,250 options to buy
@ $0 |
|
| 09/14/2021 |
4
| Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Sold 12,500 shares
@ $50, valued at
$625k
Exercised 12,500 options to buy
@ $4.98, valued at
$62.3k
|
|
| 08/02/2021 |
4
| Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Sold 12,500 shares
@ $45, valued at
$562.5k
Exercised 12,500 options to buy
@ $4.98, valued at
$62.3k
|
|
| 02/16/2021 |
4
| Siegel Jolie (Chief Legal Officer) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 84,850 options to buy
@ $45.54, valued at
$3.9M
|
|
| 05/06/2020 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 161,821 shares
@ $0
Disposed/sold 60,000 options to buy
@ $6.13, valued at
$367.8k
Disposed/sold 100,000 options to buy
@ $12, valued at
$1.2M
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2020 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 65,000 shares
@ $0 |
|
| 11/25/2019 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 03/01/2019 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 60,000 options to buy
@ $6.13, valued at
$367.8k
|
|
| 03/01/2019 |
3
| Siegel Jolie (VP, General Counsel) has filed a Form 3 on Neon Therapeutics, Inc. |
|
|